Chlorogenic acid inhibits hepatocellular carcinoma in vitro and in vivo

J Nutr Biochem. 2017 Aug:46:68-73. doi: 10.1016/j.jnutbio.2017.04.007. Epub 2017 Apr 18.

Abstract

Curative treatment of patients with hepatocellular carcinoma (HCC) is poor. There is an urgent need to develop more effective strategies for the chemoprevention of HCC. Chlorogenic acid (CGA), a type of polyphenol present in the diet, especially from coffee, has many biological activities. Patients with viral hepatitis who drank coffee everyday experienced a reduction in the incidence of HCC. In the present study, we evaluated the effects of CGA on HCC. CGA inhibited the proliferation of HepG2 cells in vitro and the progression of HepG2 xenograft in vivo. CGA induced the inactivation of ERK1/2 and suppressed the expression of MMP-2 and MMP-9 in HepG2 xenograft tissue. These data demonstrate that CGA can prevent the progression of HCC through multiple pathways. CGA appears to be an effective chemopreventive agent for hepatocellular carcinoma.

Keywords: Chemoprevention; Chlorogenic acid; Chlorogenic acid (PubChem CID: 1794427); ERK; Hepatocellular carcinoma; MMP.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Agents / pharmacology*
  • Carcinoma, Hepatocellular / drug therapy*
  • Carcinoma, Hepatocellular / pathology
  • Cell Proliferation / drug effects
  • Chlorogenic Acid / pharmacology*
  • Enzyme Activation / drug effects
  • Hep G2 Cells
  • Humans
  • Liver Neoplasms / drug therapy*
  • Liver Neoplasms / pathology
  • Male
  • Matrix Metalloproteinase 2 / metabolism
  • Mice, Inbred BALB C
  • Mitogen-Activated Protein Kinase 1 / metabolism
  • Tissue Inhibitor of Metalloproteinase-2 / metabolism
  • Xenograft Model Antitumor Assays

Substances

  • Antineoplastic Agents
  • TIMP2 protein, human
  • Tissue Inhibitor of Metalloproteinase-2
  • Chlorogenic Acid
  • MAPK1 protein, human
  • Mitogen-Activated Protein Kinase 1
  • Matrix Metalloproteinase 2